Manufacture

As fast as gene therapies are progessing, there's still one major hurdle to overcome: cost

To effectively develop advanced therapies, you need the right supply chain management

We need to stop companies from using loopholes to sell unproven cell therapies to desperate patients

A handful of cell- and gene-based therapies have now been approved, and more are sure to follow.

A consortium aims to tackle cardiovascular disease with cell therapies

Can cell and gene therapies paint a picture of perfect future health?

Tracing the supply chain back to raw materials and learning how fundamental research is driving advances in cell culture media.

Raymond Sackler, philanthropist, psychopharmacology pioneer, and former CEO of Purdue Pharma, dies aged 97.

Can enzyme immobilization enhance biocatalysis further?

Steve Davis details some of the PATH's success stories in global health.